• Skip to content (access key 1)
  • Skip to search (access key 7)
FWF — Austrian Science Fund
  • Go to overview page Discover

    • Research Radar
      • Research Radar Archives 1974–1994
      • Open API
    • Discoveries
      • Emmanuelle Charpentier
      • Adrian Constantin
      • Monika Henzinger
      • Ferenc Krausz
      • Wolfgang Lutz
      • Walter Pohl
      • Christa Schleper
      • Elly Tanaka
      • Anton Zeilinger
    • Impact Stories
      • Verena Gassner
      • Wolfgang Lechner
      • Birgit Mitter
      • Oliver Spadiut
      • Georg Winter
    • scilog Magazine
    • Austrian Science Awards
      • FWF Wittgenstein Awards
      • FWF ASTRA Awards
      • FWF START Awards
      • Award Ceremony
    • excellent=austria
      • Clusters of Excellence
      • Emerging Fields
    • In the Spotlight
      • 40 Years of Erwin Schrödinger Fellowships
      • Quantum Austria
    • Dialogs and Talks
      • think.beyond Summit
    • Knowledge Transfer Events
    • E-Book Library
  • Go to overview page Funding

    • Portfolio
      • excellent=austria
        • Clusters of Excellence
        • Emerging Fields
      • Projects
        • Principal Investigator Projects
        • Principal Investigator Projects International
        • Clinical Research
        • 1000 Ideas
        • Arts-Based Research
        • FWF Wittgenstein Award
      • Careers
        • ESPRIT
        • FWF ASTRA Awards
        • Erwin Schrödinger
        • doc.funds
        • doc.funds.connect
      • Collaborations
        • Specialized Research Groups
        • Special Research Areas
        • Research Groups
        • International – Multilateral Initiatives
        • #ConnectingMinds
      • Communication
        • Top Citizen Science
        • Science Communication
        • Book Publications
        • Digital Publications
        • Open-Access Block Grant
      • Subject-Specific Funding
        • Belmont Forum
        • ERA-NET HERA
        • ERA-NET NORFACE
        • ERA-NET QuantERA
        • Alternative Methods to Animal Testing
        • European Partnership BE READY
        • European Partnership Biodiversa+
        • European Partnership BrainHealth
        • European Partnership ERA4Health
        • European Partnership ERDERA
        • European Partnership EUPAHW
        • European Partnership FutureFoodS
        • European Partnership OHAMR
        • European Partnership PerMed
        • European Partnership Water4All
        • Gottfried and Vera Weiss Award
        • LUKE – Ukraine
        • netidee SCIENCE
        • Herzfelder Foundation Projects
        • Quantum Austria
        • Rückenwind Funding Bonus
        • TRANSCAN
        • WE&ME Award
        • Zero Emissions Award
      • International Collaborations
        • Belgium/Flanders
        • Germany
        • France
        • Italy/South Tyrol
        • Japan
        • Korea
        • Luxembourg
        • Poland
        • Switzerland
        • Slovenia
        • Taiwan
        • Tyrol-South Tyrol-Trentino
        • Czech Republic
        • Hungary
    • Step by Step
      • Find Funding
      • Submitting Your Application
      • International Peer Review
      • Funding Decisions
      • Carrying out Your Project
      • Closing Your Project
      • Further Information
        • Integrity and Ethics
        • Inclusion
        • Applying from Abroad
        • Personnel Costs
        • PROFI
        • Final Project Reports
        • Final Project Report Survey
    • FAQ
      • Project Phase PROFI
      • Project Phase Ad Personam
      • Expiring Programs
        • Elise Richter and Elise Richter PEEK
        • FWF START Awards
        • AI Mission Austria
  • Go to overview page About Us

    • Mission Statement
    • FWF Video
    • Values
    • Facts and Figures
    • Annual Report
    • What We Do
      • Research Funding
        • Matching Funds Initiative
      • International Collaborations
      • Studies and Publications
      • Equal Opportunities and Diversity
        • Objectives and Principles
        • Measures
        • Creating Awareness of Bias in the Review Process
        • Terms and Definitions
        • Your Career in Cutting-Edge Research
      • Open Science
        • Open-Access Policy
          • Open-Access Policy for Peer-Reviewed Publications
          • Open-Access Policy for Peer-Reviewed Book Publications
          • Open-Access Policy for Research Data
        • Research Data Management
        • Citizen Science
        • Open Science Infrastructures
        • Open Science Funding
      • Evaluations and Quality Assurance
      • Academic Integrity
      • Science Communication
      • Philanthropy
      • Sustainability
    • History
    • Legal Basis
    • Organization
      • Executive Bodies
        • Executive Board
        • Supervisory Board
        • Assembly of Delegates
        • Scientific Board
        • Juries
      • FWF Office
    • Jobs at FWF
  • Go to overview page News

    • News
    • Press
      • Logos
    • Calendar
      • Post an Event
      • FWF Informational Events
    • Job Openings
      • Enter Job Opening
    • Newsletter
  • Discovering
    what
    matters.

    FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

    SOCIAL MEDIA

    • LinkedIn, external URL, opens in a new window
    • , external URL, opens in a new window
    • Facebook, external URL, opens in a new window
    • Instagram, external URL, opens in a new window
    • YouTube, external URL, opens in a new window

    SCILOG

    • Scilog — The science magazine of the Austrian Science Fund (FWF)
  • elane login, external URL, opens in a new window
  • Scilog external URL, opens in a new window
  • de Wechsle zu Deutsch

  

Inhalation of natural products against lung infections

Lea Ann Dailey (ORCID: 0000-0002-4908-7122)
  • Grant DOI 10.55776/P35115
  • Funding program Principal Investigator Projects
  • Status ended
  • Start January 17, 2022
  • End January 16, 2026
  • Funding amount € 312,810

Disciplines

Biology (25%); Medical-Theoretical Sciences, Pharmacy (75%)

Keywords

  • Acute Respiratory Infection,
  • Natural Products,
  • Anti-Infectives,
  • Inhalation Biopharmaceutical Classification System,
  • Pulmonary Pharmacokinetics
Abstract Final report

Most lung infections are viral (such as COVID-19) or bacterial in nature. Currently there are few treatment options for viral infections. Bacterial infections can be treated with available antibiotics but the development of resistance to these treatments is always a concern. Natural products, such as plants and fungi, contain a wealth of antiviral or antibacterial compounds just waiting to be discovered. However, not all of these active compounds retain their efficacy when administered as a tablet or capsule. In these cases, the inhalation of anti-infective drugs offers a promising alternative. Inhalers, like the ones used for asthma treatments, can deliver the drugs directly to the site of infection in the lung, sometimes at much higher concentrations. This can greatly improve the treatment success rate. In our project, we are testing whether newly discovered compounds from natural products, will benefit from an inhalation therapy option. The results of our study will contribute to expanding the treatment options for patients suffering from acute lung infections.

Lung infections can be caused by either viruses (such as COVID-19) or bacteria. Currently, there is only a limited selection of effective medications for viral lung infections. Natural products such as plants and fungi are often sources of multipotent active ingredients, although not all of these substances are effective when administered orally. Inhalation offers a promising approach for treating lung infections. Inhalers used in the treatment of asthma can also be used for infectious diseases. Ideally, inhaling anti-infectives leads to higher drug concentrations in the lungs, allowing for targeted treatment of the infection. In our project, we investigated novel active ingredients from nature and demonstrated that inhalation administration of these substances could offer therapeutic advantages. The results of this study contribute to expanding the therapeutic options for acute lung infections through the use of natural products.

Research institution(s)
  • Universität Wien - 100%
Project participants
  • Johannes Kirchmair, Universität Wien , national collaboration partner
  • Judith Maria Rollinger, Universität Wien , national collaboration partner
  • Richard D. Harvey, Universität Wien , national collaboration partner
International project participants
  • Michaela Schmidtke, Klinikum der Friedrich-Schiller-Universität Jena - Germany
  • Forbes Ben, King´s College London

Research Output

  • 60 Citations
  • 9 Publications
  • 1 Methods & Materials
  • 1 Fundings
Publications
  • 2025
    Title Pulmonary delivery of anti-infectives from natural sources: Development and characterization of liposomal sanggenon formulations
    DOI 10.1016/j.ejps.2025.107361
    Type Journal Article
    Author Schwarzinger J
    Journal European Journal of Pharmaceutical Sciences
    Pages 107361
    Link Publication
  • 2025
    Title Effects of orally applied sanggenons C and D in BALB/c mice
    DOI 10.1016/j.phytol.2025.103559
    Type Journal Article
    Author Langeder J
    Journal Phytochemistry Letters
    Pages 103559
  • 2025
    Title Biochemometric 2D NMR-Based Heterocovariance Analysis: A Targeted Approach for Identifying Bioactive Compounds in Complex Mixtures
    DOI 10.1021/acs.analchem.5c02419
    Type Journal Article
    Author Adelsberger S
    Journal Analytical Chemistry
    Pages 22508-22517
    Link Publication
  • 2024
    Title Biopharmaceutical profiling of anti-infective sanggenons from Morus alba root bark for inhalation administration
    DOI 10.1016/j.ijpx.2024.100272
    Type Journal Article
    Author Schwarzinger J
    Journal International Journal of Pharmaceutics: X
    Pages 100272
    Link Publication
  • 2025
    Title Biochemometrics and biopharmaceutical profiling in drug discovery from natural sources
    Type PhD Thesis
    Author Sigrid Adelsberger
    Link Publication
  • 2023
    Title Correlation of bioactive marker compounds of an orally applied Morus alba root bark extract with toxicity and efficacy in BALB/c mice
    DOI 10.3389/fphar.2023.1193118
    Type Journal Article
    Author Langeder J
    Journal Frontiers in Pharmacology
    Pages 1193118
    Link Publication
  • 2023
    Title Molecular networking unveils anti-SARS-CoV-2 constituents from traditionally used remedies
    DOI 10.1016/j.jep.2023.117206
    Type Journal Article
    Author Wasilewicz A
    Journal Journal of Ethnopharmacology
    Pages 117206
  • 2023
    Title Identification of Natural Products Inhibiting SARS-CoV-2 by Targeting Viral Proteases: A Combined in Silico and in Vitro Approach
    DOI 10.1021/acs.jnatprod.2c00843
    Type Journal Article
    Author Wasilewicz A
    Journal Journal of Natural Products
    Pages 264-275
    Link Publication
  • 2023
    Title Discovery of anti-SARS-CoV-2 secondary metabolites from the heartwood of Pterocarpus santalinus using multi-informative molecular networking
    DOI 10.3389/fmolb.2023.1202394
    Type Journal Article
    Author Wasilewicz A
    Journal Frontiers in Molecular Biosciences
    Pages 1202394
    Link Publication
Methods & Materials
  • 2025
    Title Biochemometric 2D NMR-Based Heterocovariance Analysis
    DOI 10.1021/acs.analchem.5c02419
    Type Technology assay or reagent
    Public Access
Fundings
  • 2025
    Title Anti-Infectives Drug Discovery
    Type Research grant (including intramural programme)
    DOI 10.55776/doc3579124
    Start of Funding 2025
    Funder Austrian Science Fund (FWF) Department of Pharmaceutical Sciences

Discovering
what
matters.

Newsletter

FWF-Newsletter Press-Newsletter Calendar-Newsletter Job-Newsletter scilog-Newsletter

Contact

Austrian Science Fund (FWF)
Georg-Coch-Platz 2
(Entrance Wiesingerstraße 4)
1010 Vienna

office(at)fwf.ac.at
+43 1 505 67 40

General information

  • Job Openings
  • Jobs at FWF
  • Press
  • Philanthropy
  • scilog
  • FWF Office
  • Social Media Directory
  • LinkedIn, external URL, opens in a new window
  • , external URL, opens in a new window
  • Facebook, external URL, opens in a new window
  • Instagram, external URL, opens in a new window
  • YouTube, external URL, opens in a new window
  • Cookies
  • Whistleblowing/Complaints Management
  • Accessibility Statement
  • Data Protection
  • IFG-Form
  • Acknowledgements
  • © Österreichischer Wissenschaftsfonds FWF
© Österreichischer Wissenschaftsfonds FWF